A detailed history of Alphabet Inc. transactions in Vaccitech PLC stock. As of the latest transaction made, Alphabet Inc. holds 1,513,644 shares of VACC stock, worth $5.16 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
1,513,644
Previous 1,513,644 -0.0%
Holding current value
$5.16 Million
Previous $5.16 Million -0.0%
% of portfolio
0.35%
Previous 0.32%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Nov 14, 2022

SELL
$4.51 - $11.75 $860,057 - $2.24 Million
-190,700 Reduced 11.19%
1,513,644 $7.87 Million
Q4 2021

Nov 14, 2022

SELL
$8.98 - $15.55 $898 - $1,555
-100 Reduced 0.01%
1,704,344 $18.9 Million
Q2 2021

Nov 14, 2022

BUY
$13.03 - $17.0 $22.2 Million - $29 Million
1,704,444 New
1,704,444 $28.6 Million

Others Institutions Holding VACC

About Vaccitech plc


  • Ticker VACC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,216,200
  • Market Cap $127M
  • Description
  • Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...
More about VACC
Track This Portfolio

Track Alphabet Inc. Portfolio

Follow Alphabet Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphabet Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alphabet Inc. with notifications on news.